2026년 5월 13일 수요일

S&S Tech (101490) Analysis 2026 — EUV Blank Mask Localization and Valuation

S&S Tech (101490) Company Analysis — EUV Blank Mask Localization Transition and Valuation Overview

S&S Tech is a domestically listed company that manufactures blank masks — a critical material in semiconductor photolithography — across all generations from ArF and KrF to EUV. Q1 2026 revenue grew 38% year-over-year with a marked improvement in profitability, and whether the company can secure entry into Samsung Electronics' EUV process supply chain has emerged as the key variable determining its medium-term growth trajectory.


1. Company Overview and Core Business

S&S Tech (101490) designs and manufactures blank masks used in semiconductor photolithography, and has supplied ArF and KrF blank masks to domestic and international customers as its primary products. In the second half of 2024, the company completed a dedicated EUV blank mask production building at its Yongin, Gyeonggi-do facility, establishing a manufacturing base for next-generation exposure materials. Q1 2026 revenue rose 38% year-over-year and operating profit grew 61%, driven primarily by growing blank mask demand in China and an improved product mix. As of May 13, 2026, market capitalization stands at approximately KRW 1.0 trillion.

📌 Q1 2026 operating profit up 61% year-over-year — driven by China demand expansion and improved product mix

2. Core Product Competitiveness Analysis

S&S Tech's core competitive strength lies in its accumulated domestic mass-production track record in ArF·KrF blank masks and the technological continuity extending into the EUV generation. The existing EUV blank mask market has been dominated by overseas suppliers such as Japan's HOYA, and S&S Tech is currently in the final evaluation stage with Samsung Electronics following the completion of its dedicated Yongin facility. Should EUV blank mask mass production commence in earnest, management has publicly stated an annual revenue contribution target of up to KRW 500 billion*2, though the company remains in the pre-qualification phase.

CategoryDetails
PositionDomestic combined ArF·KrF·EUV blank mask manufacturer; final qualification evaluation with Samsung Electronics underway
Competitive AdvantageDedicated EUV facility in operation; ArF·KrF mass-production track record and China demand tailwind
Competitive DisadvantageEUV mass-production qualification not yet completed; no EUV supply reference record compared to overseas peers (HOYA, etc.)

3. Valuation Analysis

Based on the current price of KRW 89,000, the Trailing PER stands at 32.7x — approximately 60% below the electronic components sector average of 81.0x. PBR is 6.12x, while ROE of 19.1% and an operating margin of 20.7% indicate top-tier profitability within the sector. A debt-to-equity ratio of 29.2% reflects a sound financial structure. The sector average Forward PER of 41.3x incorporates expected EPS improvement; however, a directional shift from Trailing PER of 32.7x toward that level requires validation through actual quarterly EPS improvement inclusive of EUV business contribution*1.

📌 Trailing PER 32.7x — approximately 60% discount to sector average of 81.0x; actual quarterly EPS improvement is a prerequisite for re-rating

MetricCurrentSector Avg.Interpretation
Trailing PER32.7x81.0x~60% discount to sector
Forward PER41.3xBased on expected earnings improvement
PBR6.12xPremium to book value
ROE19.1%Strong profitability
Operating Margin20.7%Top-tier within sector
Debt-to-Equity29.2%Sound financial structure

4. Risks and Monitoring Points

A delay in Samsung Electronics' EUV blank mask qualification timeline would concentrate the growth path on existing China-facing ArF·KrF demand and defer revenue diversification. Changes in China's semiconductor investment policy or tightened export controls represent external risks that directly affect China-facing demand, which currently underpins the company's earnings growth.

  • ⚠️ Samsung Electronics EUV blank mask qualification delay — timing of mass-production transition remains uncertain, leaving EUV revenue contribution date undefined
  • ⚠️ Tightened export controls to China or a slowdown in China's semiconductor investment could reduce ArF·KrF revenue

  • 📌 Official announcement of Samsung Electronics EUV blank mask qualification completion (watch from Q2 2026 onward)
  • 📌 Whether quarterly operating margin holds above 20% — benchmark for confirming the sustainability of product mix improvement

5. Recent DART Disclosures

As of the report date (2026-05-13), no DART disclosures with high relevance to this report were identified; this section is therefore omitted.

S&S Tech is sustaining profitability from its ArF·KrF blank mask base while advancing through the qualification stage for EUV generation entry. The sector discount implied by a Trailing PER of 32.7x is a structure in which re-rating will be assessed only once EUV qualification completion and its actual quarterly earnings contribution are confirmed in reported figures.


📎 출처 및 추정 근거

  1. 1 The sector average Forward PER of 41.3x is the electronic components sector aggregate from TradeAlert DB as of 2026-05-13. Convergence from Trailing PER of 32.7x toward the Forward PER level is a conditional directional outcome contingent on actual quarterly EPS improvement being confirmed; whether this will be achieved remains undetermined at the current point in time.
  2. 2 The annual revenue target of KRW 500 billion is a figure publicly stated by S&S Tech management for the scenario in which EUV blank mask mass production ramps in earnest (based on Financial News reporting). Samsung Electronics' final qualification evaluation is currently ongoing; both the timing of mass-production commencement and the achievability of the target remain undetermined.


본 보고서는 정보 제공 목적이며 투자 권유가 아닙니다. 투자 결정은 본인 책임입니다.

⚠️ 본 포스트는 투자 참고용 정보이며, 투자 권유가 아닙니다. 모든 투자 판단과 책임은 투자자 본인에게 있습니다.

댓글 없음:

댓글 쓰기

Hyundai Glovis (086280) Company Analysis 2026: PCTC & CKD Growth and Valuation

Hyundai Glovis (086280) In-Depth Analysis: PCTC Fleet Expansion and Emerging-Market CKD Volume Drive 2026 Revenue Forecast Above KRW 32T (≈...